Cellulite: Is there a role for injectables?

Journal of Cosmetic and Laser Therapy

Volumn 7, Issue 3-4, 2005, Pages 147-154

  Rotunda, Adam M ^a   Avram, Mathew M ^b   Avram, Alison Sharpe ^c  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NONE

Author keywords

Cellulite; Deoxycholate; Fat; Mesotherapy; Phosphatidylcholine

Indexed keywords

ADIPOCYTE; CONFERENCE PAPER; DERMATOLOGICAL PROCEDURES; EUROPE; EVALUATION; HUMAN; LIPOLYSIS; MEDICAL LITERATURE; MESOTHERAPY; PEER REVIEW; PHYSICIAN; PRIORITY JOURNAL; PUBLIC HEALTH SERVICE; THEORETICAL STUDY;

ADIPOSE TISSUE; COSMETIC TECHNIQUES; DERMATOLOGIC AGENTS; HUMANS; INJECTIONS, INTRALESIONAL; LIPOLYSIS;

EID: 30944468946     PISSN: 1462883X     EISSN: 14764180     Source Type: Journal    
DOI: 10.1080/14764170500430234     Document Type: Conference Paper

References (129)

1. Pistor M. What is mesotherapy? Chir Dent Fr. 1976;46:59-60.
2. Guazzetti R, Iotti E, Marinoni E. Mesotherapy with naproxin sodium in musculoskeletal diseases. Riv Eur Sci Med Farmacol. 1988;10:539-42.
3. Donini I, De Anna D, Carella G, et al. Mesotherapy in the treatment of lymphedema: histologic and ultrastructural observations. Chir Patol Sper. 1982;30:25-34.
4. Gallo R. Mesotherapy in phlebology. Phlebologie. 1980;33:153-6.
5. Medioni G. Orodental mesotherapy. Chir Dent Fr. 1976;46:97-102.
6. Medioni G. Results of 6 years of treatment of painful periodontal episodes by mesotherapy. Chir Dent Fr. 1980;50:35-7.
7. Rotunda AM, Kolodney M. Mesotherapy and phosphatidylcholine injections: historical clarification and review. Dermatol Surg. 2005 (in press).
8. American Society for Aesthetic Plastic Surgery, Cellulite: an update. 11 August 2004. URL: http://www.surgery.org/press/news-release.php?iid=212#top
9. Stahl L. Sound of success. 48 Hours. 2 August 2003. URL.
10. Gallegos D. Liposuction alternative targets fat cells. Denver Post, 2 August 2004,.
11. American Society for Aesthetic Plastic Surgery, Liposuction (lipoplasty) without surgery update? 15 July 2004. URL: http://www.cbsnews.com/stories/2003/ 04/28/48hours/main551361.shtml,.
12. Leisenring A. Thinjections. 3 November 2003. URL: http://www.elle.com/ article.asp?section_id=36&article_id=2694&page_number=1
13. American Society for Aesthetic Plastic Surgery, Fat-melting fad: too good to be true? 5 November 2004. URL: http://www.surgery.org/press/news-release. php?iid=387
14. The Saturday Early Show, Burn fat away with an injection? 30 November 2002. URL: http://www.cbsnews.com/stories/2002/11/27/earlyshow/saturday/ main531099.shtml,.
15. Rotunda AM, Suzuki H, Moy RL, Kolodney M. Detergent effects of sodium deoxycholate are a major feature of an injectable phosphatidylcholine formulation used for localized fat dissolution. Dermatol Surg. 2004;30:1001-8.
16. Matarasso A, Pfeifer T. Mesotherapy for body contouring. Plast Reconstr Surg. 2005;115:1420-4.
17. Avram M. Cellulite: a review of its physiology and treatment. J Cosmet Laser Ther. 2004;6:181-5.
18. Draelos Z, Marenus K. Cellulite etiology and purported treatment. Dermatol Surg. 1997;23:1177-81.
19. Nürnberger F, Müller G. So-called cellulite: an invented disease. J Dermatol Surg Oncol. 1978;4:221-9.
20. Scherwitz C, Braun-Falco O. So-called cellulite. J Dermatol Surg Oncol. 1978;4:230-4.
21. Rossi ABR, Vergnanini A. Cellulite: a review. J Eur Acad Dermatol Venereol. 2000;14:251-62.
22. Curri S. Cellulite and fatty tissue microcirculation. Cosmetic Toilet. 1993;108:51-8.
23. Curri SB, Bambardelli E. Local lipodystrophy and districtual micro-circulation. Cosmetic Toilet. 1994;109:51-65.
24. Lotti T, Ghersetich I, Grappone C, et al. Proteoglycans in so-called cellulite. Int J Dermotol. 1990;29:272-4.
25. Kligman A. Cellulite: facts and fiction. J Geriatric Dermatol. 1997;5:136-9.
26. Rosenbaum M, Prieto V, Hellmer J, et al. An exploratory investigation of the morphology and biochemistry of cellulite. Plast Reconstr Surg. 1998;101:1934-9.
27. Piérard GE, Nizet JL, Piérard-Franchimont C. Cellulite: from standing fat herniation to hypodermal stretch marks. Am J Dermatopathol. 2000;22:34-7.
28. Querleux B, Cornillon C, Jolivet O, et al. Anatomy and physiology of subcutaneous adipose tissue by in vivo magnetic resonance imaging and spectroscopy: relationships with sex and presence of cellulite. Skin Res Technol. 2002;8:118-24.
29. Lucassen GW, van der Sluys WLN, van Herk JJ, et al. The effectiveness of message treatment on cellulite as monitored by ultrasound imaging. Skin Res Technol. 1997;3:154-60.
30. Prins JB, O'Rahilly S. Regulation of adipose cell number in man. Clin Sci. 1997;92:3-11.
31. Ramsay T. Fat cells. Endocrinol Metab Clin North Am. 1996;25:847-70.
32. Londos C, Brasaemle DL, Schultz CJ, et al. On the control of lipolysis in adipocytes. Ann N Y Acad Sci. 1999; 892:155-68.
33. Arner P. Control of lipolysis and its relevance to development of obesity in men. Diabetes Metab Rev. 1988; 4:507-15.
34. Iwao N, Oshida Y, Sato Y. Regional difference in lipolysis caused by a beta-adrenergic agonist as determined by the microdialysis technique. Acta Physiol Scand. 1997;161: 481-7.
35. Leibel RL, Ebens NK, Fried S. Physiologic basis for the control of body fat distribution in humans. Ann Rev Nutr. 1989;9:417-43.
36. Mauriege P, Galitzky J, Berlan M, et al. Heterogeneous distribution of beta- and alpha-2 adrenoreceptor binding sites in human fat cells from various deposits: functional consequences. Eur J Clin Invest. 1987;17:156-65.
37. Coppack SW, Jensen MD, Miles J. In vivo regulation of lipolysis in humans. J Lipid Res. 1994;35:177-93.
38. Wajchenberg B. Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome. Endocr Rev. 2000;21:697-738.
39. Lonnqvist F, Krief S, Strosberg AD, et al. Evidence for a functional beta-adrenoreceptor in man. Br J Pharmacol. 1993;110:929-36.
40. Østerlund T. Structure-function relationships of hormone-sensitive lipase. Eur J Biochem. 2001;268:1899-907.
41. Belfrage P, Fredrikson G, Nilsson NO, et al. Regulation of adipose tissue lipolysis: phosphorylation of hormone-sensitive lipase in intact rat adipocytes. FEBS Lett. 1980;111:120-4.
42. Holm C, Langin D, Manganiello VC, et al. Regulation of hormone-sensitive lipase activity in adipose tissue. Methods Enzymol. 1997;286:45-67.
43. Steinberg D, Huttunen J. The role of cyclic AMP in activation of hormone-sensitive lipase of adipose tissue. Adv Cyclic Nucleotide Res. 1972;1:47-62.
44. Egan JJ, Greenberg AS, Chang MK, et al. Mechanism of hormone-stimulated lipolysis in adipocytes: translocation of cytosolic hormone-sensitive lipase to the surfaces of lipid storage droplets. Proc Natl Acad Sci U S A. 1992;89: 8537-41.
45. Clifford GM, Londos C, Kraemer FB, et al. Translocation of hormone-sensitive lipase and perilipin upon lipolytic stimulation of rat adipocytes. J Biol Chem. 2000;275: 5011-15.
46. Lafontan M, Berlan M, Galitzky J, et al. Alpha-2 adrenoreceptors in lipolysis: alpha 2 antagonists and lipid mobilizing strategies. Am J Clin Nutr. 1992;55:S219-27.
47. Kobilka BK, Matsui H, Kobilka T. Cloning sequencing and expression of the gene coding for the human platelet alpha-2 adrenergic receptor. Science. 1987;238:650.
48. Wahrenberg H, Lonnqvist F, Arner P. Mechanisms underlying regional differences in lipolysis in human adipose tissue. J Clin Invest. 1989;84:458-67.
49. Castan I, Valet P, Larrouy D, et al. Distribution of PYY receptors in human fat cells: An antilipolytic system alongside the alpha 2-adrenergic one. Am J Physiol. 1993;265:E74-80.
50. Berlan M, Lafontan M. Evidence that epinephrine acts preferentially as an antilipolytic agent in abdominal human subcutaneous fat cells: Assessment by analysis of beta and alpha 2-adrenoreceptor properties. Eur J Clin Invest. 1985;15:341-8.
51. Arner P, Hellstrom L, Wahrenberg H, et al. Beta-adrenoreceptor expression in human fat cells from different regions. J Clin Invest. 1990;86:1595-600.
52. Arner P. Differences in lipolysis between human subcutaneous and omental adipose tissue. Ann Med. 1995;27:435-8.
53. Manganiello VC, Degerman E, Taira M, et al. Type III cyclic nucleotide phosphodiesterases and insulin action. Curr Top Cell Regul. 1996;34:63-100.
54. Degerman E, Belfrage P, Manganiello V. Structure, localization, and regulation of cGMP-inhibited phosphodiesterase (PDE3). J Biol Chem. 1997;272:6823-6.
55. Snyder PB, Esselstyn JM, Loughney K, et al. The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis. J Lipid Res. 2005;46:494-503.
56. Honnor RC, Dhillon GS, Londos C. cAMP-independent protein kinase and lipolysis in rat adipocytes. II. Definition of steady-state relationship with lipolytic and antilipolytic modulators. J Biol Chem. 1985;260:15 130-8.
57. Arner P. Adenosine, prostaglandins and phosphodiesterase as targets for obesity pharmacotherapy. Int J Obes Relat Metab Disord. 1993;17:S57-9.
58. Ohisalo JJ. Effects of adenosine on lipolysis in human subcutaneous fat cells. J Clin Endocrinol Metab. 1981;52:359-63.
59. LaNoue KF, Martin L. Abnormal A1 adenosine receptor function in genetic obesity. FASEB J. 1994;8:72-80.
60. Hetzler RK, Knowlton RG, Somani SM, et al. Effect of paraxanthine on FFA mobilization after intravenous caffeine administration in humans. J Appl Physiol. 1990;68:44-7.
61. Rohrich R. Mesotherapy: what is it? Does it work? Plast Reconstr Surg. 2005;115:1425.
62. American Society for Dermatologic Surgery, Emerging technology report: mesotherapy. URL: http://www.asds.net/Media/PositionStatements/ emerging_technology-mesotherapy.html
63. Asaadi M, Salas AP, Motamedi B. Mesoplasty: a new approach to non-surgical liposculpture. American Society of Plastic Surgery, Philadelphia, PA, October 9-13, 2004.
64. Nagore E, Ramos P, Botella-Estrada R, et al. Cutaneous infection with Mycobacterium fortuitum after localized microinjections (mesotherapy) treated successfully with a triple drug regimen. Acta Derm Venereol. 2001;81:291-3.
65. Cooksey RC, de Waard JH, Yakrus MA, et al. Mycobacterium cosmeticum sp. nov., a novel rapidly growing species isolated from a cosmetic infection and from a nail salon. Int J Syst Evol Microbiol. 2004;54:2385-91.
66. Marco-Bonnet J, Beylot-Barry M, Texier-Maugein J, et al. Mycobacterial bovis BCG cutaneous infections following mesotherapy: 2 cases. Ann Dermatol Venereol. 2002;129: 728-31.
67. Rosina P, Chieregato C, Miccolis D, et al. Psoriasis and side-effects of mesotherapy. Int J Dermotol. 2001;40:581-3.
68. Bessis D, Guilhou JJ, Guillot B. Localized urticaria pigmentosa triggered by mesotherapy. Dermatology. 2004;209:343-4.
69. Lee DP, Chang S. Subcutaneous nodules showing fat necrosis owing to mesotherapy. Dermatol Surg. 2005;31: 250-1.
70. Vaillant L, De Muret A, Muller C, et al. Lichenoid drug eruption after mesotherapy. Ann Dermatol Venereol. 1992;119:936-7.
71. Urbani C. Urticarial reaction to ethylenediamine in aminophylline following mesotherapy. Contact Dermatitis. 1994; 31:198-9.
72. Beer K. Mesotherapy: will it prove safe and effective? Skin Aging. 2005;13:5.
73. Wenkeova J, Kuhn E, Wenke M. Adrenergic lipolysis in human adipose tissue in vitro. Eur J Pharmacol. 1975;30:49-55.
74. Insel PA, Ostrom R. Forskolin as a tool for examining adenylyl cyclase expression, regulation, and G protein signaling. Cell Mol Neurobiol. 2003;23:305-14.
75. Arner P, Hellmer J, Hagstrom-Toft E, et al. Effect of phosphodiesterase inhibition with amrinone or theophylline on lipolysis and blood flow in human adipose tissue in vivo as measured with microdialysis. J Lipid Res. 1993;34:1737-43.
76. Parsons WJ, Ramkumar V, Stiles G. Isobutylmethylxanthine stimulates adenylate cyclase by blocking the inhibitory regulatory protein, G1. Mol Pharmacol. 1988;34:37-41.
77. Fredholm B. On the mechanism of action of theophylline and caffeine. Acta Medica Scand. 1985;217:149-53.
78. De Santis RA, Gorenstein T, Livingston JN, et al. Role of phosphodiesterase in glucagon resistance of large adipocytes. J Lipid Res. 1974;15:33-8.
79. Butcher RW, Baird CE, Sutherland E. Effects of lipolytic and antilipolytic substances on adenosine 3′,5′-monophosphate levels in isolated fate cells. J Biol Chem. 1968;243:1705-12.
80. Bellet S, Roman L, de Castro O, et al. Effect of coffee ingestion on catecholamine release. Metabolism. 1969;18: 288-91.
81. Otto W, Taylor TG, York D. Glycerol release in vitro from adipose tissue of obese (ob/ob) mice treated with thyroid hormones. J Endocrinol. 1976;71:143-55.
82. Heinonen O. Carnitine and physical exercise. Sports Med. 1996;22:109-32.
83. Ferrari R, Merli E, Cicchitelli G, et al. Therapeutic effects of 1-carnitine and propionyl-1-carnitine on cardiovascular diseases: a review. Ann N Y Acad Sci. 2004;1033:79-91.
84. Baccard N, Mechiche H, Nazeyrollas P, et al. Effects of 7-hydroxycoumarin (umbelliferone) on isolated perfused and ischemic-reperfused rat heart. Arzneimittelforschung. 2000;50:890-6.
85. Borzeix MG, Angignard J, Dedieu F, et al. Effect of a combination of coumarin derivatives and rutoside on venous and lymphatic circulations during severe constriction of the caudal vena cava in rabbits. Arzneimittelforschung. 1995;45:262-6.
86. Casley-Smith JR, Casley-Smith J. High-protein oedemas and the benzo-pyrones. Sidney, Australia: JB Lippincott, 1986.
87. Piller NB. Lymphoedema, macrophages and benzopyrones. Lymphology. 1980;13:109-19.
88. McKenna DJ, Jones K, Hughes K. Efficacy, safety, and use of ginkgo biloba in clinical and preclinical applications. Altern Ther Health Med. 2001;7:70-86, 88-90.
89. Boelsma E, Lamers RJ, Hendriks HF, et al. Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans. Planta Med. 2004;70:1052-7.
90. Leonhardt H, Grigoleit H. Effects of pentoxifylline on red blood cell deformability and blood viscosity under hyperosmolar conditions. Naunyn Schmiedebergs Arch Pharmacol. 1977;299:197-200.
91. Arner P, Bolinder J, Eliasson A, et al. Microdialysis of adipose tissue and blood for in vivo lipolysis studies. Am J Physiol. 1988;255:E737-42.
92. Stich V, Pelikanova T, Wohl P, et al. Activation of alpha2-adrenergic receptors blunts epinephrine-induced lipolysis in subcutaneous adipose tissue during a hyperinsulinemic euglycemic clamp in men. Am J Physiol. 2003;285:E599-607.
93. Boschmann M, Krupp G, Luft FC, et al. In vivo response to alpha(1)-adrenoreceptor stimulation in human white adipose tissue. Obesity Res. 2002;10:555-8.
94. Millet L, Barbe P, Lafontan M, et al. Catecholamine effects on lipolysis and blood flow in human abdominal and femoral adipose tissue. J Appl Physiol. 1998;85:181-8.
95. Arner P, Kriegholm E, Engfeldt P. In situ studies of catecholamine- induced lipolysis in human adipose tissue using microdialysis. J Pharmacol Exp Ther. 1990;254:284-8.
96. Enoksson S, Blaak E, Arner P. Forskolin potentiates isoprenaline-induced glycerol output and local blood flow in human adipose tissue in vivo. Pharmacol Toxicol. 1997;81:214-18.
97. Large V, Reynisdottir S, Eleborg L, et al. Lipolysis in human fat cells obtained under local and general anesthesia. Int J Obes Relat Metab Disord. 1997;21:78-82.
98. Smith U, Isaksson O, Nyberg G, et al. Human adipose tissue in culture. IV. Evidence for the formation of a hormone antagonist by catecholamines. Eur J Clin Invest. 1976;6:35-42.
99. Matuszek M. Studies on antilipolytic activity of antipyretics. Part II. Influence of sodium salicylate, aminophenazone, and acetophenidin on lipolysis stimulated by noradrenaline and aminophylline in vitro. Pol J Pharmacol Pharm. 1976;28:437-42.
100. Arciero PJ, Gardner AW, Calles-Escandon J, et al. Effects of caffeine ingestion on NE kinetics, fat oxidation, and energy expenditure in younger and older men. Am J Physiol. 1995;268:E1192-8.
101. Acheson KJ, Gremaud G, Meirim I, et al. Metabolic effects of caffeine in humans: Lipid oxidation or futile cycling? Am J Clin Nutr. 2004;79:40-6.
102. Costill DL, Dalsky GP, Fink W. Effects of caffeine ingestion on metabolism and exercise performance. Med Sci Sports. 1978;10:155-8.
103. Scotini E, Carpenedo F, Fassina G. New derivatives of methyl-xanthines: effect of thiocaffeine thiotheophylline and 8-phenyltheophylline on lipolysis and on phosphodiesterase activities. Pharmacol Res Commun. 1983;15:131-43.
104. Nedvidkova J, Haluzik M, Bartak V, et al. Changes of noradrenergic activity and lipolysis in the subcutaneous abdominal adipose tissue of hypo- and hyperthyroid patients: an in vivo microdialysis study. Ann N Y Acad Sci. 2004;1018:541-9.
105. Haluzik M, Nedvidkova J, Bartak V, et al. Effects of hypo-and hyperthyroidism on noradrenergic activity and glycerol concentrations in human subcutaneous abdominal adipose tissue assessed with microdialysis. J Clin Endocrinol Metabol. 2003;88:5605-8.
106. Dyck D. Dietary fat intake, supplements, and weight loss. Can J Appl Physiol. 2000;25:495-523.
107. Gimble J, Guilak F. Adipose-derived adult stem cells: isolation, characterization, and differentiation potential. Cytotherapy. 2003;5:362-9.
108. Boschert MT, Beckert BW, Puckett CL, et al. Analysis of lipocyte viability after liposuction. Plast Reconstr Surg. 2002;109:761-5.
109. Monzon JR, Basile R, Heneghan S, et al. Lipolysis in adipocytes isolated from deep and superficial subcutaneous adipose tissue. Obes Res. 2002;10:266-9.
110. Chung JH, Seo JY, Choi HR, et al. Modulation of skin collagen metabolism in aged and photoaged human skin in vivo. J Invest Dermatol. 2001;117:1218-24.
111. Brennan M, Bhatti H, Nerusu KC, et al. Matrix metalloproteinase-1 is the major collagenolytic enzyme responsible for collagen damage in UV-irradiated human skin. Photochem Photobiol. 2003;78:43-8.
112. Gerut Z. Lypolysin: the enzymatic dissolution of human fat in the lipoma model. Research and Innovations in Technology luncheon of the American Society for Aesthetic Plastic Surgery. Boston, MA, 2003.
113. Alkrad JA, Mrestani Y, Stroehl D, et al. Characterization of enzymatically digested hyaluronic acid using NMR, Raman, IR, and UV-Vis spectroscopies. J Pharm Biomed Anal. 2003;31:545-50.
114. Soparkar CN, Patrinely JR, Tschen J. Erasing restylane. Ophthal Plast Reconstr Surg. 2004;20:317-18.
115. Casley-Smith JR, Morgan RG, Piller N. Treatment of lymphedema of the arms and legs with 5,6-benzo-a-pyrone. N Engl J Med. 1993;329:1158-63.
116. Loprinzi CL, Kugler JW, Sloan JA, et al. Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med. 1999;340:346-50.
117. Casley-Smith J. Benzo-pyrones in the treatment of lymphoedema. Int Angiol. 1999;18:31-41.
118. Casley-Smith J. Treatment of lymphedema by complex physical therapy, with and without oral and topical benzopyrones: what should therapists and patients expect. Lymphology. 1996;29:76-82.
119. Plesca-Manea L, Parvu AE, Parvu M, et al. Effects of Melilotus officinalis on acute inflammation. Phytother Res. 2002;16:316-19.
120. Pastura G, Mesiti M, Saitta M, et al. Lymphedema of the upper extremity in patients operated for carcinoma of the breast: clinical experience with coumarinic extract from Melilotus officinalis. Clin Ter. 1999;150:403-8.
121. Ahlemeyer B, Krieglstein J. Neuroprotective effects of Ginkgo biloba extract. Cell Mol Life Sci. 2003;60:1779-92.
122. Mehlsen J, Drabaek H, Wiinberg N, Winther K. Effects of a Ginkgo biloba extract on forearm haemodynamics in healthy volunteers. Clin Physiol Funct Imaging. 2002;22:375-8.
123. Coe DA, Freischlag JA, Johnson D, et al. Pentoxifylline prevents endothelial damage due to ischemia and reperfusion injury. J Surg Res. 1997;67:21-5.
124. Pickens JP, Rodman SM, Wetmore S. The effects of extended perioperative pentoxifylline on random skin flap survival. Am J Otolaryngol. 1994;15:358-69.
125. Karacaoglan N, Akbas H. Effect of parenteral pentoxifylline and topical nitroglycerin on skin flap survival. Otolaryngol Head Neck Surg. 1999;120:272-4.
126. Li H, Xia N, Brausch I, et al. Flavonoids from artichoke (Cynara scolymus L.) up-regulate endothelial-type nitric-oxide synthase gene expression in human endothelial cells. J Pharmacol Exp Ther. 2004;310:926-32.
127. Grande S, Bogani P, de Saizieu A, et al. Vasomodulating potential of mediterranean wild plant extracts. J Agric Food Chem. 2004;52:5021-6.
128. Coleman WP, Hanke CW, AltTH , et al. Liposuction cosmetic surgery of the skin: Principles and practice. Philadelphia, PA: BC Decker, Inc., 1991: 213-38.
129. Arner P, Kriegholm E, Engfeldt P. In vivo interactions between beta-1 and beta-2 adrenoreceptors regulate catecholamine tachyphylaxia in human adipose tissue. J Pharmacol Exp Ther. 1991;259:317-22.